Astrana Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Astrana Health, Inc. (Nasdaq: ASTH) on June 25, 2026. The report discloses a material change in the Company's senior management team regarding the departure of the Chief Accounting Officer and the appointment of a successor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure: Glenn Sobotka, Chief Accounting Officer and principal accounting officer, will retire effective August 7, 2026. The retirement is not the result of any disagreement with the Company.
- Appointment: John Vong, currently Senior Vice President – Accounting, will succeed Mr. Sobotka as principal accounting officer effective August 7, 2026.
- Compensation: Effective July 1, 2026, Mr. Vong's annual base salary increases to $320,000. His target bonus opportunity remains unchanged.
Management Commentary and Risks
Management confirmed that Mr. Vong has extensive prior experience with the Company, having served as Chief Accounting Officer from November 2022 to March 2025 and in various finance roles since July 2022. The filing states there are no family relationships between Mr. Vong and the Company's directors or officers, and no undisclosed transactions involving Mr. Vong requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the effective date of the leadership transition (August 7, 2026) for internal accounting continuity.
- Confirm the new compensation structure for the principal accounting officer ($320,000 base salary).
- Review Mr. Vong's prior tenure and qualifications to assess the stability of the accounting function.
- Check for any subsequent filings regarding the interim period between the announcement and the effective retirement date.